Use of an oral contraceptive containing drospirenone in an extended regimen

被引:40
|
作者
Sillem, M [1 ]
Schneidereit, R
Heithecker, R
Mueck, AO
机构
[1] Klinikum Aschaffenburg, Frauenklin, Gynecol Clin, D-63739 Aschaffenburg, Germany
[2] Schering Deutschland GmbH, Berlin, Germany
[3] Schering AG, D-1000 Berlin, Germany
[4] Univ Gynecol Clin, Tubingen, Germany
关键词
oral contraceptive; drospirenone; extended regimen;
D O I
10.1080/713604447
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
As well as providing reliable contraception, modern low-dose oral contraceptives may offer some non-contraceptive advantages. Positive effects on problems such as edema with weight increase and breast tenderness, bloating, dysmenorrhea, and an improvement in skin and hair condition have been reported in several studies using an oral contraceptive containing drospirenone. If these disorders are cycle-dependent, use of the contraceptive in an extended regimen may be of additional benefit. The study reported in this paper followed 1433 women, 175 of whom took the drospirenone-containing pill continuously for between 42 and 126 days. Some symptoms of the premenstrual syndrome were influenced very satisfactorily by administration in an extended regimen.
引用
收藏
页码:162 / 169
页数:8
相关论文
共 50 条
  • [1] The use of an oral contraceptive containing ethinylestradiol and drospirenone in an extended regimen over 126 days
    Foidart, JM
    Sulak, PJ
    Schellschmidt, I
    Zimmermann, D
    CONTRACEPTION, 2006, 73 (01) : 34 - 40
  • [2] Suppression of ovarian activity with a drospirenone-containing oral contraceptive in a 24/4 regimen
    Klipping, Christine
    Duijkers, Ingrid
    Trummer, Dietmar
    Marr, Joachim
    CONTRACEPTION, 2008, 78 (01) : 16 - 25
  • [3] Safety of a new oral contraceptive containing drospirenone
    Heinemann, LAJ
    Dinger, J
    DRUG SAFETY, 2004, 27 (13) : 1001 - 1018
  • [4] Safety of a New Oral Contraceptive Containing Drospirenone
    Lothar A.J. Heinemann
    Jürgen Dinger
    Drug Safety, 2004, 27 : 1001 - 1018
  • [5] Extended regimen use of a triphasic oral contraceptive -: A pilot study
    Seidman, Larry S.
    Gersten, Janet
    Fisher, Alan
    LaGuardia, Katherine D.
    OBSTETRICS AND GYNECOLOGY, 2006, 107 (04): : 51S - 51S
  • [6] Expert opinion on a flexible extended regimen of drospirenone/ethinyl estradiol contraceptive
    Han, Leo
    Jensen, Jeffrey T.
    EXPERT OPINION ON PHARMACOTHERAPY, 2014, 15 (14) : 2071 - 2079
  • [7] Efficacy and tolerability of a monophasic combined oral contraceptive containing nomegestrol acetate and 17β-oestradiol in a 24/4 regimen, in comparison to an oral contraceptive containing ethinylestradiol and drospirenone in a 21/7 regimen
    Mansour, Diana
    Verhoeven, Carole
    Sommer, Werner
    Weisberg, Edith
    Taneepanichskul, Surasak
    Melis, Gian Benedetto
    Sundstrom-Poromaa, Inger
    Korver, Tjeerd
    EUROPEAN JOURNAL OF CONTRACEPTION AND REPRODUCTIVE HEALTH CARE, 2011, 16 (06): : 430 - 443
  • [8] Safety and efficacy of a new oral contraceptive containing drospirenone
    Shulman, LP
    JOURNAL OF REPRODUCTIVE MEDICINE, 2002, 47 (11) : 981 - 984
  • [9] Endocrine and metabolic effects of an oral contraceptive containing estetrol and drospirenone
    Klipping, Christine
    Duijkers, Ingrid
    Mawet, Marie
    Maillard, Catherine
    Bastidas, Adriana
    Jost, Maud
    Foidart, Jean-Michel
    CONTRACEPTION, 2021, 103 (04) : 213 - 221
  • [10] Effects of an oral contraceptive containing estetrol and drospirenone on ovarian function
    Duijkers, Ingrid
    Klipping, Christine
    Kinet, Virginie
    Jost, Maud
    Bastidas, Adriana
    Foidart, Jean-Michel
    CONTRACEPTION, 2021, 103 (06) : 386 - 393